Preliminary scientific studies indicate conolidine may inhibit unique ion channels, lessening neuronal excitability and restricting suffering signals. This system is particularly relevant in neuropathic soreness, the place irregular signaling results in persistent distress. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR